Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem for Sleep-Wake Disturbances in Parkinson's Disease
NCT02111122Phase 2Completed
- Start
- Apr 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oxybate in sleep disorder. Started Apr 2014; status: completed.
02
Drugs
sodium oxybate
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT02111122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111122.